FDA Cracks Down on Hims, Other Telehealth Companies Over Drug Ads

Follow Drugslib on

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 17, 2025.

via HealthDay

WEDNESDAY, Sept. 17, 2025 — Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs, including popular weight loss medications.

On Tuesday, the U.S. Food and Drug Administration (FDA) released more than 100 warning letters aimed at both drugmakers and online health companies. Among them: Hims & Hers, a telehealth platform that has made a name by selling lower-cost versions of well-known drugs, The Associated Press said.

The agency said Hims crossed the line by telling customers its compounded products contained “the same active ingredient” as Ozempic and Wegovy, even though Hims’ versions are mixed by compounding pharmacies and never reviewed by the FDA.

“Your claims imply that your products are the same as an FDA-approved product when they are not,” the warning letter said.

In response, Hims said it told consumers that compounded medicines aren’t FDA-approved and that it “looks forward to engaging” with the agency.

Compounding is the process of combining, mixing or altering ingredients to create a medication tailored to a patient’s needs, according to the National Library of Medicine.

This is the first time the FDA has targeted online platforms such as Hims directly. The company has long argued that traditional drug advertising rules don’t apply to them.

The move follows an order from President Donald Trump directing federal agencies to ensure drug ads on TV and social media are accurate.

The agency’s concerns go beyond Hims. Regulators also sent letters to Eli Lilly and Novo Nordisk, criticizing a 2024 infomercial with Oprah Winfrey that the FDA said gave a “misleading impression” of weight loss injections such as Wegovy and Zepbound, The AP reported.

While compounding drugs is sometimes allowed when FDA-approved versions are scarce, regulators recently said these drugs no longer qualify as in shortage.

Despite that, some companies continue selling “customized” doses. Hims has defended this, because it is potentially beneficial for certain patients.

Sources

  • The Associated Press, Sept. 16, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-09-18 16:18

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords